Lupin’s arm inks commercial agreement with Creso for hemp oil based cannaQIX

26 Aug 2019

Lupin’s subsidiary in South Africa-- ‘Pharma Dynamics’ has signed a Commercial Agreement with Creso Pharma (Creso) for the hemp oil based cannaQIX. Creso affords Pharma Dynamics sole distribution rights of its organic, broad spectrum hemp oil nutraceutical, cannaQIX10, across South Africa, Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Angola, Mozambique and Uganda. 

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Related Lupin Ltd. Links:

Lupin Share Price

1050.45 18.50 (1.79%) Mar 08, 18:37
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 614.85
Dr. Reddys Lab 4490.20
Lupin 1050.45
Piramal Enterprises 1917.10
Cadila Healthcare 446.10
View more..
Sensex vs Lupin
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback